BioMet ApS: Financial statements 2025
CVR: 45444651
Source: annual report 2025, Danish Business Authority
03/03/2025 – 31/12/2025
BioMet ApS (CVR 45444651) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -12,886 and a net result of DKK -12,886. Equity in the 2025 report amounted to DKK 187,114. The solvency ratio was 97.1%.
- Gross Profit
- DKK -12,886
- Profit/Loss
- DKK -12,886
- Equity
- DKK 187,114
- Total Assets
- DKK 192,739
- Employees
- 0
Official annual report
How creditworthy is BioMet ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of March 3, 2025, Lars Ditlev Mørck Ottosen is registered as director of BioMet ApS.
As of March 3, 2025, Mads Ujarak Sieborg is registered as director of BioMet ApS.
As of March 3, 2025, Michael Vedel Wegener Kofoed is registered as director of BioMet ApS.
As of March 3, 2025, Thomas Lundgaard is registered as director of BioMet ApS.
As of March 3, 2025, Lars Ditlev Mørck Ottosen is registered as an owner of BioMet ApS with an ownership share of 25%.
As of March 3, 2025, Mads Ujarak Sieborg is registered as an owner of BioMet ApS with an ownership share of 25%.
As of March 3, 2025, Michael Vedel Wegener Kofoed is registered as an owner of BioMet ApS with an ownership share of 25%.
As of March 3, 2025, Thomas Lundgaard is registered as an owner of BioMet ApS with an ownership share of 25%.
BioMet ApS was founded on March 3, 2025.
About BioMet ApS
BioMet ApS is a Danish company of the type Anpartsselskab based in Højbjerg, founded in 2025. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lars Ditlev Mørck Ottosen, Mads Ujarak Sieborg and Michael Vedel Wegener Kofoed. The company's owners include Lars Ditlev Mørck Ottosen, Mads Ujarak Sieborg and Michael Vedel Wegener Kofoed. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,886 and a net result of DKK -12,886. Equity in the 2025 report amounted to DKK 187,114.